58487-96-0Relevant articles and documents
BTK INHIBITORS
-
Page/Page column 65, (2014/08/07)
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising the
FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS
-
Page/Page column 109, (2012/04/04)
Disclosed are the ERK inhibitors of Formula (I): (Formula (I)) and the pharmaceutically acceptable salts thereof. All substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of Formula (I).